MENU
NRSN
AS OF
Feb 3 closing price
Price
$0.92
Change
-$0.33 (-26.40%)
Capitalization
30.32M
49 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NeuroSense Therapeutics (NRSN) Ownership - Who owns NeuroSense Therapeutics?

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
30.32M
P/E Ratio
N/A
Total Cash
666K
Projected Growth
N/A
Total Debt
19K
Revenue
N/A
Risk (Beta)
5.27
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

NRSN
Capitalization
30.3M
P/E Ratio
N/A
Risk (Beta)
5.27
Dividend Yield
N/A
Total Cash
666K
Total Cash/Share
0.02
Total Debt
19K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-519K
P/B Ratio
11.70
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
0.71
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-491.23
Shares Held By Institutions
375K
Shares Outstanding - Current
33.1M
Total Liabilities
2.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
19.623
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NRSN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRSN showed earnings on November 26, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NRSN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com